ABSTRACT
INTRODUCTION
Diabetes is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both (1) . People with type 2 diabetes are at elevated risk for a number of serious health problems, including cardiovascular disease, premature death, blindness, kidney failure, amputations, fractures, frailty, depression, and cognitive decline and various gastrointestinal and hepatic manifestations (2) . Dyspepsia is a term describing a symptom complex thought to originate in the upper gastrointestinal (GI) tract. Epigastric pain or discomfort are the cardinal symptoms and may be associated with other symptoms such as postprandial heaviness, early satiety, and nausea. Heartburn and acid regurgitation is now not included in the definition of dyspepsia because they are usually meaning GERD or functional heartburn (3) .
Gastrointestinal (GI) symptoms are reportedly common in diabetes mellitus and are usually attributed to autonomic neuropathy (4) . Although there is evidence that GI symptoms affect the quality of life adversely (5) and represent a substantial cause of morbidity in patients with diabetes. Diabetes is associated with increased prevalence of upper and lower GI symptoms related to poor glycemic control, not the duration of the disease, the available epidemiological data relating to the prevalence of GI symptoms in diabetes are conflicting and can be challenged on methodological grounds. Gastroparesis is the prototype of gastric manifestation of DM related to the autonomic neuropathy (6) . Diabetes mellitus (DM) often results in motility disorders in the gastrointestinal tract (7) (8) (9) . Gastrointestinal and hepatic involvement can present with esophageal dysmotility, gastro-esophageal reflux disease (GERD), gastroparesis, enteropathy, nonalcoholic fatty liver disease (NAFLD) and glycogenic hepatopathy (10) . Furthermore, some patients with DM, particularly those with type 2 DM, are severely obese, which increases intra-abdominal pressure.
Helicobacter pylori infection affects approximately 50% of the world's population (11, 12) and is recognized as the major acquired factor in the pathogenesis of chronic antral gastritis, peptic ulcer disease, and gastric cancer. Identification of risk groups is very important in this respect. Some reports suggested that H. pylori might have a high prevalence among patients with diabetes (13) (14) (15) . Impairment of immune system is thought to be responsible for more frequent and more severe infections in diabetic patients (16) .
PATIENTS AND METHODS
In a retrospective study 120 patients were enrolled, 60 diabetic patients and 60 non-diabetic patients. All patients presented with dyspeptic symptoms (epigastric pain, early satiety, postprandial fullness, bloating, etc. 
RESULTS
One hundred and twenty patients were enrolled in this study, 60 patients were diabetic, the mean age was 50.2±9.56, and 37(61.6%) were male, while 23 (38.33%) were female. The remaining patients were non-diabetic, their mean age was 46.07±10.19, and 31 (51.6%) were male, while 29 (48.33%) were female.
H.pylori infection was more common among diabetic patients and the result was 49/60 patients (81.66%), while in non-diabetics the prevalence was 41/60 (68.33%), but the difference was statistically not significant and the P value was 0.72.
The infection with H.pylori among diabetic patients was not related to the duration of the disease and the level of control of diabetes status (HbA1c) and the P values were 0.095, 0.52, respectively ( Table 1) . The age and gender did not increase the risk of H.pylori infection among diabetic patients and their P values were 0.099 and 0.125, respectively. In non-diabetic patients, the age and gender did not increase the risk of H.pylori infection and their P values were 0.69 and 0.51 respectively.
The upper GI endoscopic findings (GERD, esophageal candidiasis, gastropathy, gastric and duodenal ulcers, gastric polyps, gastric stasis and malignant looking masses) were not significantly different between diabetic and non-diabetic groups (Table 2) . 
DISCUSSION
In reviewing the studies that have been done till now there is a clear contradictory in the prevalence of H. pylori infection and upper GI endoscopy findings between diabetic patients and non-diabetic patients with dyspepsia. In some reports there is an increased risk of H. pylori infection in diabetic patients, these studies depending on serology for the detection of H. pylori (17, 13, 18) . Other recent studies are showing that there is no significant relation between H. pylori infection and diabetes (19) (20) (21) (22) , and upper GI endoscopic findings are not different significantly between diabetic patients and non-diabetics.
The prevalence of H.pylori infection among diabetic patients is between (30%-80%) (23) , in our study the prevalence of H. pylori infection among diabetics is high because our area is endemic for H. pylori infection, and there is a difference between these two groups but statistically not significant.
It is well known that diabetic patients are liable to get an infection, because of suppressed immunity, but there is another mechanism in which the secretion of hydrochloric acid decreased by the effect of diabetes on gastric mucosa that is harmful to the H. pylori bacteria (24) . In this study, the duration of diabetes and the level of HbA1c increase the risk of H. pylori infection but statistically not significant.
In conclusion, although H. pylori infection is more common among diabetics than nondiabetic patients such difference was not statistically significant. There was no significant difference in upper GI endoscopic findings between diabetic and non-diabetic groups.
